Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication by Prins Martin H et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Cardiovascular Disorders
Open Access Research article
Functional claudication distance: a reliable and valid measurement 
to assess functional limitation in patients with intermittent 
claudication
Lotte M Kruidenier1, Saskia PA Nicolaï1, Edith M Willigendael1, Rob A de 
Bie2, Martin H Prins2 and Joep AW Teijink*1
Address: 1Department of Surgery, Atrium medical centre Parkstad, PO Box 4446, 6401 CX Heerlen, the Netherlands and 2Department of 
Epidemiology and Caphri research School, Maastricht University, Maastricht, the Netherlands
Email: Lotte M Kruidenier - l.kruidenier@gmail.com; Saskia PA Nicolaï - exitpad@gmail.com; 
Edith M Willigendael - willigendael@hotmail.com; Rob A de Bie - RA.debie@epid.unimaas.nl; Martin H Prins - mh.prins@epid.unimaas.nl; 
Joep AW Teijink* - j.teijink@atriummc.nl
* Corresponding author    
Abstract
Background: Disease severity and functional impairment in patients with intermittent claudication
is usually quantified by the measurement of pain-free walking distance (intermittent claudication
distance, ICD) and maximal walking distance (absolute claudication distance, ACD). However, the
distance at which a patient would prefer to stop because of claudication pain seems a definition that
is more correspondent with the actual daily life walking distance. We conducted a study in which
the distance a patient prefers to stop was defined as the functional claudication distance (FCD), and
estimated the reliability and validity of this measurement.
Methods:  In this clinical validity study we included patients with intermittent claudication,
following a supervised exercise therapy program. The first study part consisted of two standardised
treadmill tests. During each test ICD, FCD and ACD were determined. Primary endpoint was the
reliability as represented by the calculated intra-class correlation coefficients. In the second study
part patients performed a standardised treadmill test and filled out the Rand-36 questionnaire.
Spearman's rho was calculated to assess validity.
Results: The intra-class correlation coefficients of ICD, FCD and ACD were 0.940, 0.959, and
0.975 respectively. FCD correlated significantly with five out of nine domains, namely physical
function (rho = 0.571), physical role (rho = 0.532), vitality (rho = 0.416), pain (rho = 0.416) and
health change (rho = 0.414).
Conclusion: FCD is a reliable and valid measurement for determining functional capacity in trained
patients with intermittent claudication. Furthermore it seems that FCD better reflects the actual
functional impairment. In future studies, FCD could be used alongside ICD and ACD.
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Background
Intermittent claudication is a symptom of peripheral arte-
rial disease (PAD), and is described as muscle pain in the
lower extremities that is produced by exercise and relieved
in rest. Patients with intermittent claudication have lim-
ited exercise and walking capacity, which reduces their
functional capacity[1].
Treadmill testing is a common way to quantify the grade
of functional impairment. The Royal Dutch Society for
Physiotherapists recommends the administration of
treadmill tests to all patients with intermittent claudica-
tion, both to objectively document the degree of func-
tional impairment, and to evaluate therapy effect[2].
In general, two distances are measured during treadmill
testing of patients with intermittent claudication. First is
the distance walked at the onset of claudication pain, also
known as the initial claudication distance (ICD), or pain-
free walking distance. The second measurement is the dis-
tance at which claudication pain becomes so severe that
the patient is forced to stop, also known as the absolute
claudication distance (ACD), or maximal walking dis-
tance [2-6]. In the literature, both ICD and ACD are used
to classify the degree of functional impairment. Both dis-
tances have been shown to be reliable measurements with
good reproducibility. ICD appears to be less reliable in
comparison with ACD [7-13].
In patients with intermittent claudication both ICD and
ACD correlate with different quality of life domains of the
EuroQol[14], the Short-form-36[15,16], and several dis-
ease specific questionnaires [17-19]. However, the defini-
tion of both ICD and ACD is not correspondent with
distances a patient would walk in daily life. Although
most patients will continue to walk after appearance of
the first signs of pain, few will walk until their maximum
pain threshold is reached during the course of daily activ-
ities.
For this reason, the distance at which a patient prefers to
stop because of claudication pain may be a better instru-
ment by which to measure the functional impairment of
patients with intermittent claudication. Bendermacher et
al[20] first used "the distance at which a patient prefers to
stop because of claudication pain". We define this dis-
tance as the functional claudication distance (FCD).
We conducted this study, since the reliability and validity
of FCD have never been tested. Furthermore we want to
compare reliability and validity of FCD with both ICD
and ACD to determine the value of FCD for testing func-
tional impairment in patients with intermittent claudica-
tion.
Methods
Patients
Patients with intermittent claudication, following a super-
vised exercise program, were recruited from private physi-
otherapy practices in the Southern part of the
Netherlands. Inclusion criteria were intermittent claudica-
tion with an ACD of < 1600 meters on a standard tread-
mill test. Patients had to have followed at least 3 months
of community based supervised exercise therapy accord-
ing to the guidelines of the Royal Dutch Society of Physi-
otherapy to rule out therapy effect between the 2 study
measurements. Exclusion criteria were the inability to
walk on the standard treadmill protocol, serious cardiop-
ulmonary comorbidity (NYHA 3 and 4)[21] and reasons
for discontinuing the treadmill test other than intermit-
tent claudication. The study was approved by the local
research ethics committee from the Atrium medical centre
Heerlen, and all patients provided informed consent.
Study protocol
The study consisted of two parts. In the first part, 57
patients were included who performed two standardised
treadmill tests within three weeks. Patients rested for 10
minutes before each test to ensure that no claudication
pain was present at the start. Handrail support was not
allowed. In case of unbalance, the researcher gave the
patient his hand to hold on to until balance was regained.
During the treadmill tests, patients were blinded for the
distance/time walked by covering the display of the tread-
mill. The data from the first part were used to determine
reliability of ICD, FCD, and ACD.
In the second part, 25 patients were included who all per-
formed a standardised treadmill test and filled out a Rand-
36 questionnaire to determine quality of life. The Rand-36
is a general quality of life questionnaire and determines
quality of life in 9 domains of functioning[22]. Data from
the second part were used to determine validity of FCD,
compared to ICD and ACD.
Treadmill testing
A progressive treadmill test was used according to Gardner
et al[23]. with a constant speed of 3.2 km/h and an
increase in inclination of 2% every two minutes, begin-
ning with 0% inclination. The inclination and testing
duration were maximised to 10% and 30 minutes (1600
metres), respectively. Patients participating in the first part
of the study performed two treadmill tests. Patients partic-
ipating in the second part performed only one treadmill
test. During treadmill testing all patients were supervised
by one of two independent researchers. At each test all
walking distances (ICD, FCD, and ACD) were measured.
Patients indicated the onset of claudication pain, the
point of preferring to stop, and the point that maximum
walking distance was reached.BMC Cardiovascular Disorders 2009, 9:9 http://www.biomedcentral.com/1471-2261/9/9
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Analysis
Nominal and interval variables are presented as frequency
(%) and mean ± standard deviation respectively, unless
otherwise indicated. Differences in baseline characteristics
between the two groups were assessed by a Chi-square test
for nominal variables and a Paired Student's T-test for
interval variables.
To determine the reliability of ICD, FCD, and ACD, an
intra-class correlation coefficient (ICC) for absolute agree-
ment was calculated, according to a two-way mixed effects
model with random effects for subjects and a fixed effect
for time[24]. Bland-Altman plots were used to visualize
the repeated measurements[25]. Regression analysis was
applied to assess whether the difference between the two
measurements is dependent on the mean walking dis-
tance to determine if a log transformation of the Bland-
Altman plots is necessary. The extent of variability
between repeated measurements was assessed by the coef-
ficient of variation for ICD, FCD and ACD separately.
In the validity study scatter plots were used to examine the
linearity of the correlation and to detect possible outliers.
Walking distance was plotted against the value of the dif-
ferent domains of the Rand-36 questionnaire for each
patient individually. Outliers, appearing as points far
away from the overall pattern were excluded. Validity was
assessed using the Spearman's rho to calculate the degree
of correlation between ICD, FCD, and ACD and the differ-
ent domains of the Rand-36 questionnaire. Data were
analysed using SPSS 12.0.
Results
In total eighty-two patients were included in this study, of
whom 57 in the reliability part and twenty-five in the
validity part. The patient characteristics are shown in
Table 1, and as can be seen, no significant differences were
present between the two patient groups.
For one patient participating in the reliability study no
FCD was measured, for reasons unknown, resulting in 56
patients available for the reliability analysis of FCD.
The mean walking distances (ICD, FCD, and ACD) are
shown in Table 2. For every patient the FCD laid in
between ICD and ACD. The mean difference between
FCD and ACD was 104 and 106 metres for the first and
second treadmill test respectively.
Figure 1A, B, and 1C show Bland-Altman plots of ICD,
FCD and ACD, respectively. The mean value of 2 measure-
ments is plotted against the difference of measurement 1
minus measurement 2. Regression analysis did not show
that systematic differences between repeated measure-
ments were dependent on mean walking distance, indicat-
ing that a log transformation of the Bland-Altman plots
was unnecessary[25]. Differences between repeated meas-
urements as presented in the Bland-Altman plots are
equally divided above and below zero difference. This
shows that no learning/therapy effect occurred between
the two measurements.
The reliability measurements presented in Table 2 show
that the ICC of ACD (0.975, 95% CI 0.957 – 0.985) was
significantly better than the ICC of ICD (0.940, 95% CI
0.899 – 0.964). The ICC of FCD was set in between these
two, with a value of 0.959 (95% CI 0.931 – 0.976), not
significantly different from ICD or ACD. The coefficients
of variation showed corresponding results with values of
21.7%, 18.1% and 13.2% for the ICD, FCD and ACD,
respectively.
Table 1: Clinical characteristics of included patients
Characteristic Total Population
N = 82
Patients for reliability analysis
N = 57
Patients for validity analysis
N = 25
P-value
Male 49 (59.8%) 36 (63.2%) 13 (52.0%) 0.343
Age (years) 67 ± 10 68 ± 9 65 ± 12 0.213
ABI 0.69 ± 0.19 0.71 ± 0.20 0.66 ± 0.17 0.338
Weight (kg) 76 ± 14 76 ± 14 75 ± 15 0.797
Risk factors
Hypertension 60 (78.9%) 39 (76.5%) 21 (84.0%) 0.449
Diabetes Mellitus 20 (26.3%) 10 (19.6%) 10 (40.0%) 0.058
Hypercholesterolemia 43 (56.6%) 25 (49.0%) 18 (72.0%) 0.058
Smoking behaviour 0.669*
Current smoking 34 (44.7%) 22 (43.1%) 12 (48%)
Former smoking 35 (46.1%) 24 (47.1%) 11 (44.0%)
Never smoked 7 (9.2%) 5 (9.8%) 2 (8.0%)
Kg: Kilograms, ABI: ankle brachial index.
* Calculated with Kendall's-tau test.BMC Cardiovascular Disorders 2009, 9:9 http://www.biomedcentral.com/1471-2261/9/9
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Based on the scatter plots two patients were identified as
outliers and excluded from the analysis, leaving 23
patients for validity analysis. The mean scores of the Rand-
36 questionnaire and the correlations of the different
walking distances with quality of life are shown in table 3.
The ICD correlated significantly with the physical func-
tion (rho = 0.473, p = 0.022) and general health (rho =
0.518, p = 0.011) domain of the Rand-36 questionnaire.
FCD correlated significantly with five out of nine
domains, namely physical function (rho = 0.571, p =
0.004)), physical role (rho = 0.532, p = 0.009), vitality
(rho = 0.416, p = 0.048), pain (rho = 0.416, p = 0.037)
and health change (rho = 0.414, p = 0.050). ACD corre-
lated with physical function (rho = 0.496, p = 0.016),
physical role (rho = 0.519, p = 0.011) and health change
(rho = 0.446, p = 0.033).
Discussion
FCD, defined as the distance when the patient prefers to
stop due to claudication, is a reliable and valid measure-
ment to determine functional impairment in patients
with intermittent claudication.
The ICC of FCD was 0.959 and in between of the ICC of
ICD and ACD, with ACD showing the most reproducible
measurements. The coefficients of variation showed corre-
sponding results. ACD showed the least variation, fol-
lowed by FCD and ICD, respectively.
FCD correlated significantly with the physical function,
physical role, vitality, pain and health change domain of
the Rand-36 questionnaire. ICD correlated significantly
with the physical function and general health domain.
Significant correlations of ACD were found with physical
function, physical role, and health change. These results
indicate that FCD corresponds best with general quality of
life as FCD correlated with five of nine domains compared
to two and three domains for ICD and ACD respectively.
In our study, ACD is the most reliable measurement dur-
ing a treadmill test. This conforms to results found in lit-
erature for several treadmill protocols [7-13]. Three
studies from Gardner et al[10,23] and Labs et al[11]
assessed the reliability of the treadmill protocol used in
this study. The ICC of ICD and ACD in these studies
ranges from 0.82 to 0.89 and from 0.93 to 0.96, respec-
tively. The coefficients of variation in these studies range
from 11.0% to 15.5% for ACD, and from 15.8% to 28.6%
for ICD. These findings are in line with coefficients of var-
iation found in our study, and indicate that ICD and ACD
are both reliable measurements. However, the ICC found
in our study tends to be better than those previously
described in the literature. One possible explanation for
this difference could be that our test population consisted
of patients familiar with treadmill testing. Prior to this
study, all patients received at least 3 months of commu-
nity based supervised exercise therapy, consisting mainly
of treadmill walking. This may have influenced the stabil-
ity of the outcomes of the treadmill tests. It seems plausi-
ble that reliability between two measurements increases
with treadmill training of the patients, as compared to
untrained patients.
In our study FCD correlates best with quality of life, fol-
lowed by ACD and ICD. In literature several studies deter-
mined correlations between QOL and walking distances.
A recent study in 48 patients from Myers et al[16] showed
a significant correlation of ICD with both pain and social
function whereas ACD correlated with physical function
and vitality measured by the short-form-36. Izquierdo-
Porrera et al[15] determined Pearson's correlation coeffi-
cients between ACD and the different domains of the
short-form-36. In this study ACD correlated significantly
with physical function (r = 0.43), physical role (r = 0.33),
and mental health (r = 0.27). Furthermore, ICD and ACD
correlate with different domains of the PAVK-86[19], the
CLAUS questionnaire[17], and the VascuQol[17].
Limitation of the study is that we included patients famil-
iar with treadmill walking, what could have influenced
the reliability results. FCD results should therefore be
measured in other patient populations and until then
treated with caution in these populations. However, cor-
responding coefficients of variation for ICD and ACD
from the literature (untrained patients) compared to our
study (trained patients) may indicate that the results from
Table 2: Mean walking distances and reliability measurements
Measurement one (metres) Measurement two (metres) ICC Value (95% CI) Coefficient of variation (%)
ICD 271.6 ± 174.9 273.7 ± 162.2 0.940
(0.899 – 0.964)
21.7%
FCD 531.2 ± 357.3 541.2 ± 339.6 0.959
(0.931 – 0.976)
18.8%
ACD 635.4 ± 376.0 642.6 ± 368.8 0.975
(0.957 – 0.985)
13.2%
SD: standard deviation, ICC: intra-class correlation coefficient, CI: confidence interval, ICD: initial claudication distance, FCD: functional 
claudication distance, ACD: absolute claudication distanceBMC Cardiovascular Disorders 2009, 9:9 http://www.biomedcentral.com/1471-2261/9/9
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Walking distances, represented by Bland-Altman plots Figure 1
Walking distances, represented by Bland-Altman plots. For ICD, FCD and ACD respectively, the mean of the two 
measurements is plotted against the difference between the two measurements.
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this study for FCD can be projected to patients unfamiliar
with treadmill walking.
A further limitation is the limited number of patients
included in the validity study (n = 23 for the analysis). A
study including more patients to confirm our results is
desirable.
The definition of FCD, the distance at which a patient pre-
fers to stop walking, assumes a better reflection of the
functional capacity of patients than ICD or ACD. In prac-
tice, most patients do not stop walking at the first indica-
tion of claudication pain, neither do they walk until they
reach their maximal pain threshold. In our study, compar-
ison of FCD with the Rand-36, for the purpose of estab-
lishing the clinical relevance shows that FCD correlates
better with quality of life than both ICD and ACD. There-
fore we think that FCD is a more important outcome
measurement from a patient's perspective. Furthermore,
from a research perspective, FCD is a reliable and valid
instrument that can be used in clinical trials. In the future
it is conceivable that training programs using a global
positioning system will be developed using a software
program calculating walking distances and recuperation
time[26] Especially in such a training environment it is
more likely that the average claudicant will stop when pre-
ferring so than until reaching a maximal pain threshold.
Conclusion
The functional claudication distance is a reliable measure-
ment for determining functional capacity in trained
patients with intermittent claudication. Furthermore it
seems that FCD better reflects the actual functional
impairment. In future studies, FCD could be used in con-
junction with ICD and ACD.
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